| File | File size | Created |
|---|---|---|
 Regional collaterals.pdf | 645 kB | Oct-2018 |
| mCTA detection of distal emboli.pdf | 1097 kB | Oct-2018 |
| Multi-phase CTA A new tool for the imaging triage of patients with acute ischemic stroke Menon et al. - 2015 - .pdf | 2598 kB | Nov-2017 |
| The future of endovascular treatment: Insights from the ESCAPE investigators | 2528 kB | Oct-2017 |
| Drip and Ship Versus Direct to Comprehensive Stroke Center Conditional Probab | 6041 kB | Oct-2017 |
| Drip ‘n Ship Versus Mothership for Endovascular Treatment Modeling the Best Tran | 488 kB | Oct-2017 |
| Denominator fallacy revisited | 750 kB | Oct-2017 |
| Multiphase CT Angiography: A New Tool for the Imaging Triage of Patients | 2598 kB | Oct-2017 |
Latest Research Publications:
Clinical Course of Acute Ischemic Stroke Due to Medium Vessel Occlusion With and Without Intravenous Alteplase Treatment
CONCLUSIONS: One of every 2 patients with MeVO did not achieve excellent clinical outcome at 90 days with best medical management. Early recanalization was strongly associated with excellent outcome but occurred in <50% of patients despite intravenous alteplase treatment.
Utility of Time-Variant Multiphase CTA Color Maps in Outcome Prediction for Acute Ischemic Stroke Due to Anterior Circulation Large Vessel Occlusion
CONCLUSION: In this study, collateral extent assessment on time-variant mCTA maps improved prediction of good outcome and has similar value in predicting follow-up infarct volume compared to conventional mCTA collateral grading.
Effect of age and baseline ASPECTS on outcomes in large-vessel occlusion stroke: results from the HERMES collaboration
CONCLUSION: There was no multiplicative interaction of age and ASPECTS on clinical outcomes in EVT or control arm patients. Outcomes in patients ≥75 years with ASPECTS 0-5 were poor, irrespective of treatment. Further investigation to define the role of EVT and range of acceptable outcomes in this subgroup is warranted.
Physician factors influencing endovascular treatment decisions in the management of unruptured intracranial aneurysms
CONCLUSION: Although several predictors of endovascular treatment decision were identified, there seems to be a high degree of uncertainty when estimating rupture risks, treatment complications, and treatment success for endovascular UIA treatment. More data on the clinical course of UIAs with and without endovascular treatment is needed.
